Microprocessor-Controlled Knee and Powered/ Microprocessor Ankle-Foot Prostheses — Coverage Criteria
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Massachusetts Policy 133 alerts
Get alerted when Policy 133 changes without checking for updates manually.
Monitor payer policy activity
Medical necessity and coverage criteria for microprocessor-controlled knees and investigational stance on powered knees and microprocessor/powered ankle-foot prostheses for commercial members of Blue Cross Blue Shield - Massachusetts.
Clarified coding information.
Prior authorization requests may be submitted using Authorization Manager.
Coverage and Medical Necessity Criteria
Medical Necessity for Microprocessor-Controlled Knee
Covered when ALL of the following are met
[[chunk 3]]
Typically daily and frequent need of 2 or more activities would be needed to show benefit [[chunk 3]]
[[chunk 3]]
Contraindications and fitting criteria apply [[chunk 4],[chunk 5]]
Investigational / Not Supported
The following are considered investigational (not covered) due to insufficient evidence
[[chunk 5],[chunk 17]]
[[chunk 5],[chunk 18]]
Evidence-based coverage summary
Coverage decision informed by available evidence:
Insufficient evidence to determine improvement in net health outcome for powered knees and powered/microprocessor ankle-foot devices [[chunk 17],[chunk 18]]
Powered knees, and microprocessor-controlled or powered ankle-foot prostheses are designated as investigational (not covered) in this policy. The policy text states that a "powered knee is considered INVESTIGATIONAL" and that "microprocessor-controlled or powered foot is considered INVESTIGATIONAL," which excludes these devices from coverage for commercial members when requested for the investigational indications described.
The investigational designation is reflected in the HCPCS listing for powered/microprocessor ankle-foot components (for example, L5969 and L5973), which the policy groups as investigational codes.
The document does not enumerate additional explicit blanket exclusions beyond the investigational designation, but it notes that the limited and insufficient evidence supporting powered ankle-foot prostheses means coverage for these devices is constrained where the sole justification is improved functional outcomes. In other words, absence of strong evidence of net health benefit informs limits on coverage decisions for powered ankle-foot devices.
Contraindications that make an individual inappropriate for a microprocessor knee — and may lead to denial — include: inability to tolerate the weight of the prosthesis; any condition that prevents socket fitting (for example, complicated wound or intractable pain); Medicare functional levels K0 (no ability or potential to ambulate), K1 (limited transfer/ambulation on level ground), or certain K2 presentations that lack the cardiovascular reserve, strength, or balance to benefit; inability to use swing and stance features of the knee unit; poor balance or ataxia; significant deformity of the residual limb; limited cognitive ability to understand gait sequencing or device care; and falling outside manufacturer weight/height guidelines. Environmental or maintenance limitations (for example, inability to charge the device, excessive moisture/dust, or extremely rural settings) are also listed as contraindications.
For powered ankle-foot prostheses specifically, the policy states that the available evidence is limited and does not support an improvement in functional outcomes compared with standard prostheses. The summary concludes that evidence is insufficient to determine an improvement in net health outcome for powered ankle-foot components, and therefore their use to achieve better functional outcomes is not supported.
Coding and Billing
| L5615 | Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance_phase control |
| L5856 | Addition to lower extremity prosthesis, endoskeletal knee-shin system, microprocessor control feature, swing and stance phase, includes electronic sensor(s) any type |
| L5857 | Addition to lower extremity prosthesis, endoskeletal knee-shin system, microprocessor control feature, swing phase only, includes electronic sensor(s), any type |
| L5858 | Addition to lower extremity prosthesis, endoskeletal knee shin system, microprocessor control feature, stance phase only, includes electronic sensor(s), any type |
| FOZZICZ | |
| FOZZIDZ | Gait Training/Functional Ambulation Treatment using Electrotherapeutic Equipment |
| FOZZIEZ | |
| FOZZIFZ | Gait Training/Functional Ambulation Treatment using Assistive, Adaptive, Supportive or Protective Equipment |
| FOZZIGZ | Gait Training/Functional Ambulation Treatment using Aerobic Endurance and Conditioning Equipment |
| FOZZIUZ | Gait Training/Functional Ambulation_Treatment using_Prosthesis |
| FOZZ9YZ | |
| FOZZIZZ | Gait Training/Functional Ambulation Treatment |
| FODZGEZ | Dynamic Orthosis Device Fitting_using Orthosis_ |
| FODZGFZ | Dynamic Orthosis Device Fitting using Assistive, Adaptive, Supportive or Protective Equipment |
| No codes listed |
Provider Requirements, Authorization, and Documentation
Prior authorization required for microprocessor knee services
Precertification/preauthorization is required for services described in this policy for commercial members; outpatient prior authorization is required for Managed Care (HMO and POS) and PPO plans.
- Applies to Commercial Members (Managed Care HMO/POS, PPO, Indemnity).
- Prior authorization required for inpatient and outpatient settings as specified.
Prior authorization required (per policy history)
Policy history clarifies prior authorization processes and directs providers to submit prior authorization requests using the Authorization Manager.
- Policy history entry 9/2023: clarified to include prior authorization requests using Authorization Manager.
- Policy history entry 1/2024: coding information clarified (operational note).
Trial with standard prosthesis before microprocessor knee
For individuals whose potential benefit from a microprocessor knee is uncertain, providers should consider a trial fitting with a standard prosthesis to evaluate tolerability and function before prescribing a microprocessor-controlled knee.
- Trial period may be indicated to evaluate tolerability and efficacy in a real-life setting.
- Use trial results to determine whether microprocessor knee offers incremental benefit over standard prosthesis.
Action not specified
No summary available for this placeholder callout in the inventory.
Authorization submission and documentation notes
Submit authorization requests using Authorization Manager and include the appropriate servicing provider NPI/provider ID and the facility NPI/provider ID; ensure submitted documentation supports meeting the medical necessity criteria for the requested HCPCS codes.
- Enter the servicing surgeon's NPI/provider ID (not the billing group).
- Enter the facility NPI/provider ID for the site of service.
- Include documentation of activity level, ambulation needs (e.g., ≥400 continuous yards), cognitive and cardiopulmonary ability as applicable.
Follow prior authorization procedures
Follow payer-specific prior authorization processes as described in policy history and use Authorization Manager for prior authorization submissions.
- Refer to policy history for operational and coding clarifications that may affect submission.
- Use Authorization Manager (available 24/7) to request authorizations, submit clinical documentation, and check case status.
Contraindications that may lead to denial
Contraindications listed in the policy may make a candidate unsuitable and can lead to denial if documented: inability to tolerate prosthesis weight; conditions preventing socket fitting (eg, complicated wound or intractable pain); Medicare K0/K1/K2 functional levels; inability to use swing/stance features; poor balance/ataxia; limited cognitive ability; falls outside manufacturer weight/height guidelines; environmental or maintenance limitations.
- Inability to tolerate weight of the prosthesis.
- Any condition preventing socket fitting (complicated wound, intractable pain).
- Medicare functional levels K0, K1, or K2 as described.
- Inability to use swing and stance features; poor balance or ataxia; limited cognitive ability.
- Fails manufacturer weight/height guidelines or has unsuitable environmental/maintenance conditions.
Evidence insufficiency may trigger denial
Requests for powered ankle-foot prostheses to improve functional outcomes may be denied because the limited evidence does not support improved functional outcomes compared with standard prostheses.
- Limited evidence available to date does not support improvement in functional outcomes with powered ankle-foot prostheses.
- Evidence is insufficient to conclude an improvement in net health outcome for these devices.
Background and Rationale
Microprocessor-controlled prostheses use sensors and electronic control to adjust joint behavior in real time with the intent of improving safety and function across variable walking conditions. The policy describes expected benefits for appropriate candidates — such as increased independence, reduced risk of falls, decreased energy expenditure for longer distances, potential to unload the contralateral limb, and facilitating return to a more active lifestyle — when the patient has adequate strength, balance, cardiovascular reserve, and cognitive ability to use and maintain the device.
Definitions and Functional Classifications
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.